A Cybersecurity Awareness Month series from Thompson Coburn’s Data Governance, Privacy and Cybersecurity practice group
Throughout Cybersecurity Awareness Month, Thompson Coburn is examining how organizations can put AI to work while maintaining control over their information. Our series focuses on
In a recent Law360 article, Thompson Coburn attorneys Michele Kloeppel, Sarah Larson, and Christian Witte examined the potential impact of the SEC’s proposed rescission of Rule 14a-8 and the role states may play in shaping the future of
Starting December 12, 2026, many New York employers must keep an opioid antagonist, an overdose reversal medication, available at the workplace.
Governor Hochul signed the law in December 2025. A February 2026 amendment clarified that the medication must be available
In a recent Chief Healthcare Executive article, Thompson Coburn Health Care attorneys Mackenzie Wallace and Ashton Dietrich examined the growing pressures rural hospitals face when negotiating with Medicare Advantage and commercial payers.
The article outlines key considerations surrounding network adequacy requirements, reimbursement
On October 1, 2026, the U.S. Department of Justice (“DOJ”) issued Directive 26-12, Corporate Enforcement in the Fight Against Fraud (the “Directive”), which sets out the priorities and approach that will govern the investigation and prosecution of corporate fraud by
A Cybersecurity Awareness Month series from Thompson Coburn’s Data Governance, Privacy and Cybersecurity practice group
In 2020, a hacker went undetected for three months inside the network of Blackbaud, a South Carolina company that provides fundraising, financial, and administrative software
In a recent Law360 article, Thompson Coburn attorneys Brent Trame, Nabil Al-Khaled, and Christian Witte examine how recent SEC actions and a proposed rescission of Rule 14a-8 could significantly reshape the shareholder proposal process and corporate governance landscape.
Reese’s Peanut Butter Pumpkins may not have had the jack-o’-lantern faces pictured on their packaging, but a federal court concluded that those missing details did not give consumers a concrete injury sufficient to support a proposed class action.
In Vidal
The Sixth Circuit has wiped out a $31.8 million jury verdict that Hello Farms, a licensed Michigan cultivator, had won against Curaleaf subsidiaries for walking away from a supply contract. The court’s reasoning was direct: federal courts cannot enforce agreements
For some time, Title IX compliance has come with an odd disconnect. Institutions have been following the 2020 Title IX regulations, but the official text in the Code of Federal Regulations (CFR) still showed the 2024 rule that courts had
